TNXPTonix Pharmaceuticals Holdi...

Nasdaq tonixpharma.com


$ 0.15 $ -0.01 (-5.93 %)    

Monday, 16-Sep-2024 15:59:14 EDT
QQQ $ 473.14 $ -2.10 (-0.44 %)
DIA $ 417.33 $ 2.44 (0.59 %)
SPY $ 562.48 $ 0.83 (0.15 %)
TLT $ 101.29 $ 0.92 (0.92 %)
GLD $ 238.61 $ -0.02 (-0.01 %)
$ 0.1475
$ 0.15
$ 0.15 x 4,400
-- x --
$ 0.15 - $ 0.15
$ 0.13 - $ 29.76
12,634,766
na
3.25M
$ -0.11
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-16-2024 06-30-2024 10-Q
2 05-13-2024 03-31-2024 10-Q
3 04-01-2024 12-31-2023 10-K
4 11-09-2023 09-30-2023 10-Q
5 08-10-2023 06-30-2023 10-Q
6 05-08-2023 03-31-2023 10-Q
7 03-13-2023 12-31-2022 10-K
8 11-07-2022 09-30-2022 10-Q
9 08-08-2022 06-30-2022 10-Q
10 05-09-2022 03-31-2022 10-Q
11 03-14-2022 12-31-2021 10-K
12 11-08-2021 09-30-2021 10-Q
13 08-09-2021 06-30-2021 10-Q
14 05-10-2021 03-31-2021 10-Q
15 03-15-2021 12-31-2020 10-K
16 11-09-2020 09-30-2020 10-Q
17 08-10-2020 06-30-2020 10-Q
18 05-12-2020 03-31-2020 10-Q
19 03-24-2020 12-31-2019 10-K
20 11-08-2019 09-30-2019 10-Q
21 08-12-2019 06-30-2019 10-Q
22 05-13-2019 03-31-2019 10-Q
23 03-18-2019 12-31-2018 10-K
24 11-09-2018 09-30-2018 10-Q
25 08-13-2018 06-30-2018 10-Q
26 05-11-2018 03-31-2018 10-Q
27 03-09-2018 12-31-2017 10-K
28 11-06-2017 09-30-2017 10-Q
29 08-11-2017 06-30-2017 10-Q
30 05-12-2017 03-31-2017 10-Q
31 04-13-2017 12-31-2016 10-K
32 11-10-2016 09-30-2016 10-Q
33 08-05-2016 06-30-2016 10-Q
34 05-06-2016 03-31-2016 10-Q
35 03-03-2016 12-31-2015 10-K
36 11-06-2015 09-30-2015 10-Q
37 08-07-2015 06-30-2015 10-Q
38 05-08-2015 03-31-2015 10-Q
39 02-27-2015 12-31-2014 10-K
40 11-07-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

- Bloomberg

Core News & Articles

- Reuters Citing State TV

 whats-going-on-with-tonix-pharmaceuticals-tnxp-stock

Tonix Pharmaceuticals shares jumped 38% after presenting data on TNX-801, a potential single-dose mpox vaccine. Preclinical stu...

 tonix-pharmaceuticals-presented-data-on-its-potential-mpox-vaccine-tnx-801-in-using-synthetic-biology-to-battle-mpox-talk-at-immunology-symposium-at-the-university-of-alberta-tnx-801-vaccination-demonstrated-efficacy-in-protecting-animals-from-lethal-challenge-with-clade-i-mpox

New data show improved tolerability in immunocompromised animals and no evidence of spreading to blood or tissues even at high ...

Core News & Articles

 - Reuters

Core News & Articles

https://www.nbcnews.com/health/health-news/us-prepares-possible-arrival-severe-strain-mpox-rcna169926 Senior Biden administrati...

Core News & Articles

https://ec.europa.eu/commission/presscorner/detail/en/ip_24_4523 Today, close to 100,000 mpox vaccine doses will arrive in the ...

Core News & Articles

- Reuters

Core News & Articles

https://www.reviewjournal.com/life/health/mpox-case-reported-at-clark-county-detention-center-3148320/ One case of mpox has bee...

Core News & Articles

- Reuters 

 tonix-pharma-collaborates-with-worlds-largest-vaccine-manufacturer-for-mpox-vaccine

Tonix Pharmaceuticals and Bilthoven Biologicals have partnered to advance TNX-801, a promising mpox vaccine candidate based on ...

Core News & Articles

https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-member-states-information-sessio...

 tonix-pharmaceuticals-says-it-is-developing-a-vaccine-candidate-called-tnx-801-as-who-declared-mpox-a-public-health-emergency-of-international-concern-on-aug-14

Tonix has successfully completed non-human primate studies showing protection from challenge with lethal doses of the Clade 1 m...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION